Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NUP62CL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RRM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC105374177 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DHFR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AREG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASXL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FANCI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHF19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZC3H8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYAR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH3BP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGAP11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCARNA13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COX11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on